Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [Phase 3]
A Phase 3 randomized trial comparing adjuvant epirubicin/cyclophosphamide followed by a taxane versus epirubicin/taxane for node-positive br…
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. [Phase 3]
Phase 3 trial evaluating zoledronic acid to prevent cancer treatment-related bone loss in postmenopausal women with breast cancer receiving …
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Role of Gene Variation in Effectiveness of Gleevec Treatment
A completed clinical trial evaluated whether genetic variation influences the effectiveness of imatinib (Gleevec) in cancer, including breas…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: E3 Breast Cancer Taxotere Combination [Phase 2]
A Phase 2 trial evaluating a Taxotere (docetaxel) combination for advanced breast cancer, with results posted in May 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating two combination regimens for advanced breast cancer (pemetrexed-carboplatin and gemcitabine-vinorelbine) h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-05-20Clinical Trial Update: APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)
Update on the APOLLO study, a patient compliance program for aromatase inhibitors including a quality-of-life questionnaire, in breast cance…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer [Phase 3]
A Phase III trial evaluating PROCRIT (epoetin alfa) versus placebo in women undergoing adjuvant chemotherapy for breast cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating epoetin alfa for the treatment of anemia in cancer patients receiving chemotherapy; study completed.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT) [Phase 2]
This update reports that the Phase 2 trial of ixabepilone in HER-2 negative metastatic breast cancer has been terminated.
-
FDA approval · 2011-05-17FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASLODEX (fulvestrant) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of SU-014813 in patients with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy [Phase 4]
This update reports the completion of a Phase 4 trial evaluating autologous fat grafts enriched with regenerative cells to reconstruct breas…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer [Phase 2]
Phase 2 study evaluating a three-drug regimen of epirubicin, docetaxel, and capecitabine in women with Stage IIIA/IIIB breast cancer has com…
-
CLINICAL_TRIALS research · 2011-05-16Clinical Trial Update: Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer
ClinicalTrials.gov update describing a pharmacogenetics study of anastrozole in postmenopausal women with ER/PR-positive breast cancer (stag…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer [NA]
The record indicates completion of a clinical trial studying biopsy samples in women with metastatic breast cancer undergoing first-line che…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer [Phase 2]
Phase 2 trial evaluating whether granulocyte colony-stimulating factor can prevent chemotherapy-induced neutropenia in women with breast can…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery [Phase 3]
A Phase 3 trial comparing 6 months versus 12 months of trastuzumab in women with nonmetastatic, surgically resectable breast cancer has been…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
This completed trial investigated whether circulating tumor cell levels in blood can predict response to first-line chemotherapy in patients…
-
CLINICAL_TRIALS research · 2011-05-12Clinical Trial Update: The Use of Major Depression Inventory (MDI) in Measuring Preoperative Depressive Symptoms in Breast Cancer Patients
A completed clinical trial evaluating the Major Depression Inventory as a measure of preoperative depressive symptoms in breast cancer patie…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women
This clinical trial update reports outcomes of letrozole treatment in postmenopausal women with breast cancer, stratified by estrogen recept…
-
CLINICAL_TRIALS research · 2011-05-11Clinical Trial Update: Adjuvant AI Combined With Zoladex [Phase 3]
Phase 3 trial update investigating adjuvant aromatase inhibitor combined with Zoladex for breast cancer; current status not specified.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of docetaxel and oxaliplatin in patients with recurrent or metastatic breast cancer.
-
CLINICAL_TRIALS research · 2011-05-11Clinical Trial Update: Korean Hereditary Breast Cancer Study
An update on a Korean hereditary breast cancer study sponsored by the Korean Breast Cancer Study Group. The study covers breast cancer and o…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors [Phase 1]
A Phase 1 clinical trial update evaluating the combination of paclitaxel and bortezomib in patients with metastatic or unresectable malignan…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer [Phase 2]
A Phase 2 study comparing anastrozole plus gefitinib to fulvestrant plus gefitinib in postmenopausal women with metastatic breast cancer; re…